润迈德-B(02297)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02297 润迈德-B

休市中 10-16 15:55:33

0.170

+0.001

+0.59%

最高0.176	最低0.165	成交量13.80万
今开0.176	昨收0.169	日振幅6.51%
总市值2.38亿	流通市值2.38亿	总股本14.01亿
成交额2.30万	换手率0.01%	流通股本14.01亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02297","market":"HK","secType":"STK","nameCN":"润迈德-B","latestPrice":0.17,"timestamp":1792137333798,"preClose":0.169,"halted":0,"volume":138000,"delay":0,"changeRate":0.0059171597633136145,"floatShares":1401000000,"shares":1401000000,"eps":-0.07003307999340778,"marketStatus":"休市中","change":0.001,"latestTime":"10-16 15:55:33","open":0.176,"high":0.176,"low":0.165,"amount":23015,"amplitude":0.065089,"askPrice":0.17,"askSize":78000,"bidPrice":0.147,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.05827521323465936,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":7,"adr":0,"listingDate":1657209600000,"exchange":"SEHK","adjPreClose":0.169,"openAndCloseTimeList":[[1792114200000,1792123200000],[1792126800000,1792137600000]],"volumeRatio":6.699029171740975,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02297","defaultTab":"news","newsList":[{"id":"1143569640","title":"润迈德-B公布2026年9月股份变动月报表，股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1143569640","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143569640?lang=zh_cn&edition=full","pubTime":"2026-10-02 12:06","pubTimestamp":1790913995,"startTime":"0","endTime":"0","summary":"润迈德医医疗有限公司于2026年10月2日披露截至2026年9月30日的股份变动月报表。当月公司已发行普通股数量与库存股份数量均保持不变，分别为1,401,358,800股和0股，股本结构未发生变化。在股份期权方面，公司“于2021年12月10日采纳的首次公开发售前购股权计划”中，本月内注销389,250份股份期权，截至9月末的剩余股份期权数量为20,824,650份。公告显示，公司当月未进行新增发行、股份回购及注销操作。股本总体维持稳定。公告由联席公司秘书张亮签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185291310","title":"润迈德-B2026年中期营收14.7百万元，经调整净亏损23.0百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185291310","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185291310?lang=zh_cn&edition=full","pubTime":"2026-09-25 16:17","pubTimestamp":1790324248,"startTime":"0","endTime":"0","summary":"截至2026年6月30日止六个月，润迈德-B录得营收14.7百万元人民币，同比增加约41%。毛利率从去年同期的49.2%提升至63.2%。经调整净亏损为23.0百万元人民币，较上一年同期的33.3百万元收窄约30.9%。经营活动使用现金流量净额为17.2百万元。公司整体成本结构持续改善，销售费用约11.3百万元，同比下降25.1%；研发费用为4.9百万元，同比下降22.7%；一般及行政开支为16.8百万元，同比下降18.5%，主要由于薪酬及日常开支减少。FlashAngio caFFR系统销售额为75千元，上年同期为66千元；","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"润迈德-B2026年中期营收14.7百万元，经调整净亏损23.0百万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187713599","title":"润迈德-B(02297)：王霖辞任非执董　陆逊9月4日接任","url":"https://stock-news.laohu8.com/highlight/detail?id=1187713599","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187713599?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:33","pubTimestamp":1788514437,"startTime":"0","endTime":"0","summary":"润迈德-B9月4日发布公告，董事会接纳王霖先生因专注其他工作事务，自2026年9月4日起辞任公司非执行董事。王霖先生确认与董事会无意见分歧，且无需就其离任事项另行提请股东或香港联交所关注。董事会对其任职期间所作贡献表示感谢。同日，公司宣布委任陆逊先生为非执行董事，任期自2026年9月4日起至公司下届股东周年大会结束为止，届时其可依法重新当选连任，此后将按公司章程轮换退任及重选。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104611358","title":"润迈德医疗-B（02297）公布董事会组成及委员会任命","url":"https://stock-news.laohu8.com/highlight/detail?id=1104611358","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104611358?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:33","pubTimestamp":1788514422,"startTime":"0","endTime":"0","summary":"润迈德医疗有限公司于2026年9月4日发布公告，披露最新版董事会成员名单及其在董事会下设各专门委员会中的职务安排。公告中未披露其他财务或运营数据。公司强调，所有委员会任命均在公告日期起生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664338237","title":"润迈德-B(02297)委任陆逊为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2664338237","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664338237?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:23","pubTimestamp":1788513789,"startTime":"0","endTime":"0","summary":"智通财经APP讯，润迈德-B(02297)公布，王霖先生因需要投放更多时间于其他工作事务而辞任非执行董事，陆逊先生已获委任为非执行董事，均自2026年9月4日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02297","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165664789","title":"润迈德-B更新2026年8月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1165664789","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165664789?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:06","pubTimestamp":1788253606,"startTime":"0","endTime":"0","summary":"润迈德医疗有限公司于2026年9月1日公布截至2026年8月31日止的股份变动月报表。报告显示，公司法定/注册股本与已发行股份总数在本月均未发生变化，股本结构保持稳定。根据公告，润迈德-B目前法定/注册股本为3,800,000,000股，面值为每股0.0001港元，股本总额为380,000港元；本月底已发行股份总数为1,401,358,800股，与上月持平，未进行新增发行或购回、注销及库藏股变动。截至报告期末，公司股本维持不变，上述公告由联席公司秘书张亮交付。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071746","title":"润迈德-B(02297)发布中期业绩 股东应占亏损2198.9万元 同比收窄31.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071746","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663071746?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:06","pubTimestamp":1788170782,"startTime":"0","endTime":"0","summary":"智通财经APP讯，润迈德-B(02297)发布截至2026年6月30日止6个月中期业绩，该集团期内取得收入1467.2万元，同比增加41.01%;公司股东应占亏损2198.9万元，同比收窄31.65%;每股基本亏损0.02元。公告称，收益增加主要由于FlashPressure caFFR压力传感器的销售增加。同时，集团的冠状动脉切割球囊作为集中带量采购品种，于报告期间开始实现销售收益约139万元。随着集采政策的持续推进及覆盖医院的逐步增加，该产品的销售量预期将稳步提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188294244","title":"润迈德-B2026年上半年营收14.7百万元，经调整净亏损22.0百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188294244","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188294244?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:03","pubTimestamp":1788170604,"startTime":"0","endTime":"0","summary":"润迈德-B公告显示，2026年上半年营业收入为14.7百万元，同比增长41.3%；毛利为9.3百万元，同比增长82.4%，毛利率由49.2%上升至63.2%。经调整后，公司股东应占净亏损为22.0百万元，同比减少34.9%。运营方面，报告期内经营活动所用现金净额为17.2百万元。整体流动资产净值达到116.7百万元。冠状动脉切割球囊于期内开始贡献业务收入，约为1.39百万元。成本结构方面，销售费用为11.3百万元，同比下降25.1%；研发投入4.9百万元，同比下降22.7%；管理费用16.8百万元，同比减少18.5%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"润迈德-B2026年上半年营收14.7百万元，经调整净亏损22.0百万元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115318098","title":"润迈德-B（02297）将于8月31日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1115318098","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115318098?lang=zh_cn&edition=full","pubTime":"2026-08-13 17:31","pubTimestamp":1786613490,"startTime":"0","endTime":"0","summary":"润迈德医疗有限公司（02297，以下简称“公司”）8月13日公告称，董事会已排定于2026年8月31日（星期一）召开会议，拟审议及批准公司及其附属公司截至2026年6月30日止六个月的未经审计中期业绩，并讨论是否派发中期股息（如有），同时处理其他相关事项。\n公告显示，截至公告日期，公司董事会由8名成员组成，包括执行董事霍云飞先生及段静女士；非执行董事霍云龙博士、王霖先生及衡磊先生；以及独立非执行董事廖船江先生、陈雪峰先生和赵晖先生。\n公司提醒，香港交易及结算所有限公司及香港联合交易所有限公司对本公告内容概不负责，并不就其准确性或完整性作出任何声明，对因依赖该内容所引致的任何损失概不承担责任。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109616226","title":"润迈德-B更新7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1109616226","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109616226?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:42","pubTimestamp":1785750137,"startTime":"0","endTime":"0","summary":"润迈德-B于2026年8月3日公布的截至2026年7月31日股份变动月报表显示，报告期内公司股本保持稳定，未发生新增发行、购回或库存股份变动。公司于本月底已发行普通股股数为1,401,358,800股，库存股份为0股，与上月底保持一致。公告最后显示，公司已履行全部适用的上市规则、法律及其他监管规定，对当月股份发行、购回及库存股份相关事项作出正式授权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145268990","title":"润迈德-B6月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1145268990","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145268990?lang=zh_cn&edition=full","pubTime":"2026-07-02 12:16","pubTimestamp":1782965787,"startTime":"0","endTime":"0","summary":"润迈德-B于2026年7月2日发布2026年6月证券变动月报表。根据公告，截至2026年6月30日，公司注册股本3,800,000,000股，面值为每股港币0.0001元，注册股本总额为港币380,000，与上月保持一致。公告显示，截至本月末，公司已发行股份总数为1,401,358,800股，无库存股份。报告期内未出现新的股份发行、购回或注销，整体股本结构保持不变。公司同时确认，截至本月末，其公众持股量符合香港联合交易所有限公司股票上市规则的相关要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641100469","title":"润迈德-B(02297)：陈绮蓝获委任为联席公司秘书及授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2641100469","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641100469?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:18","pubTimestamp":1780910306,"startTime":"0","endTime":"0","summary":"智通财经APP讯，润迈德-B(02297)发布公告，朱卓婷女士(朱女士)因工作调动，已辞任本公司联席公司秘书及香港联合交易所有限公司(联交所)证券上市规则第3.05条项下本公司的授权代表，自2026年6月8日起生效。陈绮蓝女士(陈女士)已获委任为联席公司秘书及授权代表，以接替朱女士的空缺，自2026年6月8日起生效。张亮先生将继续担任另一名联席公司秘书。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451425.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123478368","title":"润迈德-B5月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1123478368","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123478368?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:56","pubTimestamp":1780477006,"startTime":"0","endTime":"0","summary":"润迈德医疗有限公司于2026年6月3日公布截至2026年5月31日的股份变动月报表。报告显示，在本月内，公司已发行股本及库藏股规模均未发生变化，股本结构保持稳定。根据公告，截至2026年5月31日，公司法定/注册股本仍为3,800,000,000股普通股，对应注册股本380,000港元，面值每股0.0001港元。该公告由联席公司秘书张亮签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959275","title":"润迈德-B(02297)：朱则柯辞任执行董事及联席首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959275","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640959275?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:00","pubTimestamp":1780315251,"startTime":"0","endTime":"0","summary":"智通财经APP讯，润迈德-B(02297)发布公告，朱则柯先生因需要专注处理家庭事务，已辞任公司执行董事及联席首席执行官职务，自2026年6月1日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"润迈德-B(02297)：朱则柯辞任执行董事及联席首席执行官","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174103881","title":"润迈德-B4月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1174103881","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174103881?lang=zh_cn&edition=full","pubTime":"2026-05-04 16:51","pubTimestamp":1777884667,"startTime":"0","endTime":"0","summary":"润迈德-B于2026年5月4日披露了截至2026年4月30日的股份变动月报。报告期内，公司注册股本维持3,800,000,000股普通股，面值为每股0.0001港元，法定/注册股本总额仍为380,000港元。截至2026年4月30日，公司已发行股份数量为1,401,358,800股，与上月底一致，并无发行新增股份或回购、注销及库藏股变动；库藏股份数量保持为0。在首个公开发售前购股权计划中，截至报告期末，股份期权数目为21,721,050份，报告期内并无新增授出、行使或失效情况。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110509029","title":"润迈德-B2025年收入大幅回落至1,917.6万元 亏损同比收窄至7,708.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110509029","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110509029?lang=zh_cn&edition=full","pubTime":"2026-04-28 18:33","pubTimestamp":1777372388,"startTime":"0","endTime":"0","summary":"润迈德-B于2025年度在血管介入诊断及器械研发方面持续深耕，依托其cFFR系统、cAlMR系统等核心产品，进一步开拓国内外市场，并在报告期内完成收购天津悦和康生物技术有限公司68.32%股权，拓展高端医疗器械研发布局。报告期内，公司全年收入降至人民币1,917.6万元，较2024年度的人民币3,982.4万元下降51.8%，主要因为市场环境及销售节奏变化所致。净亏损则从2024年度的人民币11,349.6万元收窄至人民币7,708.3万元，降幅达32.1%。整体现金储备降至人民币1,440.5万元，同比下降73.6%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"润迈德-B2025年收入大幅回落至1,917.6万元 亏损同比收窄至7,708.3万元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187861506","title":"润迈德-B拟回购最高一成已发行股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1187861506","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187861506?lang=zh_cn&edition=full","pubTime":"2026-04-28 18:26","pubTimestamp":1777371965,"startTime":"0","endTime":"0","summary":"润迈德-B在港交所发布公告，将于2026年6月29日举行股东周年大会，计划向股东提呈普通决议案，授权董事按照香港上市规则及适用法律，从合法可动用资金中回购公司已发行股本最多10%的股份。润迈德-B方面强调，2026年6月24日至6月29日期间将暂停办理股份过户登记。董事会称，当前回购授权有助公司根据市场情况灵活管理资金与股本结构，进一步保护及提升股东权益。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"润迈德-B拟回购最高一成已发行股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517140217","title":"润迈德-B盘中异动 股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517140217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517140217?lang=zh_cn&edition=full","pubTime":"2025-03-07 11:19","pubTimestamp":1741317581,"startTime":"0","endTime":"0","summary":"2025年03月07日早盘11时19分，润迈德-B股票出现异动，股价急速拉升5.44%。截至发稿，该股报0.155港元/股，成交量23万股，换手率0.02%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。润迈德-B股票所在的医疗设备及用品行业中，整体涨幅为0.10%。润迈德-B公司简介：润迈德医疗有限公司是一家中国的投资控股公司。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307111941989f54c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307111941989f54c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517932509","title":"润迈德-B盘中异动 早盘大幅上涨5.38%报0.137港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517932509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517932509?lang=zh_cn&edition=full","pubTime":"2025-03-05 09:42","pubTimestamp":1741138941,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时42分，润迈德-B股票出现异动，股价急速上涨5.38%。截至发稿，该股报0.137港元/股，成交量16万股，换手率0.01%，振幅0.00%。资金方面，该股资金流入2.192万港元，流出0港元。最近的财报数据显示，该股实现营业收入2,943.86万港元，净利润-4,563.05万港元，每股收益-0.04港元，毛利2,043.76万港元，市盈率-1.25倍。润迈德-B股票所在的医疗设备及用品行业中，整体涨幅为0.10%。润迈德-B公司简介：润迈德医疗有限公司是一家中国的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305094221989c5c8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305094221989c5c8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516625431","title":"润迈德-B03月04日主力净流出5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2516625431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516625431?lang=zh_cn&edition=full","pubTime":"2025-03-04 17:39","pubTimestamp":1741081188,"startTime":"0","endTime":"0","summary":"03月04日, 润迈德-B股价跌10.96%，报收0.13元，成交金额36万元，换手率0.23%，振幅9.59%，量比1.15。润迈德-B今日主力资金净流出5万元，上一交易日主力净流出0万元。该股近5个交易日下跌11.64%，主力资金累计净流入16万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入24万元，其中净流入天数为4日。该股主力净额占比0.03%，港股市场排名2522/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174959a25ea7b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174959a25ea7b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02297","BK1100"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://rainmed.com","stockEarnings":[{"period":"1week","weight":0.1111},{"period":"1month","weight":0.018},{"period":"3month","weight":-0.2827},{"period":"6month","weight":-0.3818},{"period":"1year","weight":-0.4516},{"period":"ytd","weight":-0.3704}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0153},{"period":"6month","weight":-0.0754},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":-0.0563}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"润迈德医疗有限公司是一家投资控股公司。该公司主要从事与基于冠状动脉造影的血流储备分数系统（caFFR系统）、基于冠状动脉造影的微血管阻力指数系统（caIMR系统）以及体外诊断（IVD）产品相关医疗器械的研发、制造及商业化。该公司的核心产品（即caFFR系统及caIMR系统）是用于评估冠状动脉狭窄和微血管功能障碍（冠状动脉疾病（CAD）的相关起因）引起的心肌缺血严重程度的医疗器械，其设计旨在替代压力导丝的使用，大幅减少技术误差和操作时间，从而改善生理评估。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.15132},{"month":2,"riseRate":0.5,"avgChangeRate":-0.115104},{"month":3,"riseRate":0.5,"avgChangeRate":0.072953},{"month":4,"riseRate":0.5,"avgChangeRate":-0.051834},{"month":5,"riseRate":0.5,"avgChangeRate":0.07695},{"month":6,"riseRate":0.75,"avgChangeRate":-0.033226},{"month":7,"riseRate":0.25,"avgChangeRate":0.14843},{"month":8,"riseRate":0,"avgChangeRate":-0.123883},{"month":9,"riseRate":0.4,"avgChangeRate":-0.015365},{"month":10,"riseRate":0.2,"avgChangeRate":-0.107552},{"month":11,"riseRate":0.25,"avgChangeRate":-0.045447},{"month":12,"riseRate":0.25,"avgChangeRate":-0.094857}],"exchange":"SEHK","name":"润迈德-B","nameEN":"RAINMED-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"润迈德-B(02297)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供润迈德-B(02297)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"润迈德-B,02297,润迈德-B股票,润迈德-B股票老虎,润迈德-B股票老虎国际,润迈德-B行情,润迈德-B股票行情,润迈德-B股价,润迈德-B股市,润迈德-B股票价格,润迈德-B股票交易,润迈德-B股票购买,润迈德-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"润迈德-B(02297)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供润迈德-B(02297)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}